BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27344971)

  • 1. A novel synonymous mutation in the MPZ gene causing an aberrant splicing pattern and Charcot-Marie-Tooth disease type 1b.
    Corrado L; Magri S; Bagarotti A; Carecchio M; Piscosquito G; Pareyson D; Varrasi C; Vecchio D; Zonta A; Cantello R; Taroni F; D'Alfonso S
    Neuromuscul Disord; 2016 Aug; 26(8):516-20. PubMed ID: 27344971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease.
    Roa BB; Warner LE; Garcia CA; Russo D; Lovelace R; Chance PF; Lupski JR
    Hum Mutat; 1996; 7(1):36-45. PubMed ID: 8664899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B.
    Sabet A; Li J; Ghandour K; Pu Q; Wu X; Kamholz J; Shy ME; Cambi F
    Neurology; 2006 Oct; 67(7):1141-6. PubMed ID: 17030746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth 1B caused by expansion of a familial myelin protein zero (MPZ) gene duplication.
    Speevak MD; Farrell SA
    Eur J Med Genet; 2013 Oct; 56(10):566-9. PubMed ID: 23811036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset Charcot-Marie-Tooth type 1B disease caused by a novel Leu190fs mutation in the myelin protein zero gene.
    Kochański A; Kabzińska D; Drac H; Ryniewicz B; Rowińska-Marcińska K; Hausmanowa-Petrusewicz I
    Eur J Paediatr Neurol; 2004; 8(4):221-4. PubMed ID: 15261887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
    Eggers SD; Keswani SC; Melli G; Cornblath DR
    Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of the myelin protein zero gene in patients with Charcot-Marie-Tooth disease.
    Nowakowski A; Kochański A
    Acta Biochim Pol; 2004; 51(1):273-80. PubMed ID: 15094849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).
    Gharesouran J; Hosseinzadeh H; Naghiloo A; Ghafouri-Fard S; Hussen BM; Taheri M; Rezazadeh M; Samadian M
    Metab Brain Dis; 2023 Aug; 38(6):1963-1970. PubMed ID: 36952089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new MPZ mutation associated with a mild CMT1 phenotype presenting with recurrent nerve compression.
    Magot A; Latour P; Mussini JM; Mourtada R; Guiheneuc P; Pereon Y
    Muscle Nerve; 2008 Aug; 38(2):1055-9. PubMed ID: 18663734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot-Marie-Tooth disease with intermediate conduction velocities caused by a novel mutation in the MPZ gene.
    Banchs I; Casasnovas C; Montero J; Volpini V; Martínez-Matos JA
    Muscle Nerve; 2010 Aug; 42(2):184-8. PubMed ID: 20544920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of large myelin protein zero leads to Charcot-Marie-Tooth disease-like neuropathy in mice.
    Otani Y; Ohno N; Cui J; Yamaguchi Y; Baba H
    Commun Biol; 2020 Mar; 3(1):121. PubMed ID: 32170207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity.
    Young P; Grote K; Kuhlenbäumer G; Debus O; Kurlemann H; Halfter H; Funke H; Ringelstein EB; Stögbauer F
    J Neurol; 2001 May; 248(5):410-5. PubMed ID: 11437164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin protein zero gene mutations in Taiwanese patients with Charcot-Marie-Tooth disease type 1.
    Lee YC; Soong BW; Lin KP; Lee HY; Wu ZA; Kao KP
    J Neurol Sci; 2004 Apr; 219(1-2):95-100. PubMed ID: 15050444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation of myelin protein zero associated with an axonal form of Charcot-Marie-Tooth disease.
    Santoro L; Manganelli F; Di Maria E; Bordo D; Cassandrini D; Ajmar F; Mandich P; Bellone E
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):262-5. PubMed ID: 14742601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel MPZ gene mutation in exon 2 causing late-onset demyelinating Charcot-Marie-Tooth disease.
    Chavada G; Rao DG; Martindale J; Hadjivassiliou M
    J Clin Neuromuscul Dis; 2012 Jun; 13(4):206-8. PubMed ID: 22622165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and clinical spectrums in Korean Charcot-Marie-Tooth disease patients with myelin protein zero mutations.
    Kim HJ; Nam SH; Kwon HM; Lim SO; Park JH; Kim HS; Kim SB; Lee KS; Lee JE; Choi BO; Chung KW
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1678. PubMed ID: 33825325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
    Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
    Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.
    Numakura C; Lin C; Ikegami T; Guldberg P; Hayasaka K
    Hum Mutat; 2002 Nov; 20(5):392-8. PubMed ID: 12402337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Déjerine-Sottas syndrome with a silent nucleotide change of myelin protein zero gene.
    Taioli F; Cabrini I; Cavallaro T; Simonati A; Testi S; Fabrizi GM
    J Peripher Nerv Syst; 2011 Mar; 16(1):59-64. PubMed ID: 21504504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.